Ken Stern & Associates’s ExxonMobil XOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$476K Buy
5,603
+10
+0.2% +$818 0.21% 62
2018
Q2
$463K Sell
5,593
-411
-7% -$32.7K 0.21% 57
2018
Q1
$448K Sell
6,004
-63
-1% -$5.04K 0.2% 62
2017
Q4
$507K Sell
6,067
-243
-4% -$20.1K 0.22% 60
2017
Q3
$520K Sell
6,310
-71
-1% -$5.64K 0.23% 51
2017
Q2
$520K Buy
6,381
+10
+0.2% +$818 0.24% 52
2017
Q1
$520K Sell
6,371
-25
-0.4% -$2.09K 0.24% 47
2016
Q4
$577K Buy
6,396
+642
+11% +$56.1K 0.3% 35
2016
Q3
$502K Buy
5,754
+9
+0.2% +$798 0.35% 39
2016
Q2
$539K Buy
5,745
+341
+6% +$30.2K 0.42% 35
2016
Q1
$452K Buy
5,404
+771
+17% +$61.7K 0.31% 42
2015
Q4
$361K Sell
4,633
-89
-2% -$7.11K 0.24% 59
2015
Q3
$351K Buy
4,722
+576
+14% +$44.4K 0.27% 46
2015
Q2
$324K Buy
4,146
+614
+17% +$52.8K 0.23% 45
2015
Q1
$300K Buy
3,532
+741
+27% +$65.7K 0.23% 50
2014
Q4
$258K Buy
+2,791
New +$260K 0.2% 62

Other funds holding XOM

Ken Stern & Associates's XOM Position: Q3 2018 in Review

Ken Stern & Associates increased its ExxonMobil (XOM) stake by 0.18% in Q3 2018, buying an estimated $818 and bringing the position to 5,603 shares worth $476K. The position accounts for 0.21% of the portfolio, ranked #62.

Ken Stern & Associates first reported a position in XOM in Q4 2014 and has held it in 16 quarters since. The position peaked at $577K in Q4 2016. 2,424 funds tracked by Wall St. Rank hold XOM as of Q3 2018.

  • Ken Stern & Associates held 5,603 shares of ExxonMobil worth $476K as of Q3 2018.
  • Ken Stern & Associates bought 10 ExxonMobil shares in Q3 2018, an estimated $818.
  • ExxonMobil made up 0.21% of Ken Stern & Associates's portfolio in Q3 2018, its #62 holding.
  • Ken Stern & Associates first reported a position in ExxonMobil in Q4 2014 and has held it in 16 quarters since.
  • Ken Stern & Associates's ExxonMobil position peaked at $577K in Q4 2016.
  • 2,424 funds tracked by Wall St. Rank held ExxonMobil as of Q3 2018.

Based on Ken Stern & Associates's 13F filing for Q3 2018, filed 13 Nov 2018.